Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Combining liraglutide and metformin helps obese women with PCOS who didn't lose weight on metformin alone to lose more weight.

A new compound, HTPI, promotes hair growth by protecting cells from damage and regulating energy use.

Imatinib can repigment grey hair, while SU11428 can cause temporary hair depigmentation.

Combining a GnRH agonist with a low-dose oral contraceptive is more effective and safer for treating hirsutism than using either alone.

MEK and BRAF inhibitors increase sebum production and accumulation, which could cause acne-like side effects.

Cuscuta reflexa leaves extract may help lower blood sugar and improve diabetes symptoms.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

GLP-1 receptor agonists can help manage PCOS metabolism but need careful use before conception.

Retinoids can help treat skin pigmentation disorders by affecting melanin production.

Troglitazone increases subcutaneous fat in lipodystrophy patients.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

Cadd4 effectively reduces cholesterol levels without side effects.

Biosimilars lower costs but don't significantly improve access.

A new topical method using peptides boosts hair growth effectively with less finasteride and fewer side effects.

New chemicals were made that can block an enzyme linked to hair loss, prostate growth, and acne.

New steroids were patented as effective for treating acne, hair loss, and other conditions related to hormones.

GLP-1 therapies can cause hair loss, but hair often regrows after stopping or reducing the drug.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

Irisin and GIP levels are not linked to BMI in women, regardless of PCOS status.

The model and estimator can predict drug exposure in kidney transplant patients well.

A new method can almost perfectly distinguish adenomyosis from similar conditions using blood tests.

Existing drugs are being repurposed to treat cardiometabolic disorders, which is safer, faster, and cheaper than developing new drugs.

GI197111X is best dissolved in Capmul MCM for trials.

More research is needed to understand if GLP-1 agonists affect hair health.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

RSPO1 could help create new diabetes treatments by increasing pancreatic β cells.